Inhaled Corticosteroids With/Without Long-Acting β-Agonists Reduce the Risk of Rehospitalization and Death in COPD Patients-Reference-Cited by-同舟云学术

Inhaled Corticosteroids With/Without Long-Acting β-Agonists Reduce the Risk of Rehospitalization and Death in COPD Patients

Published:2003-02 Issue:1 Volume:2 Page:67-74
ISSN:1175-6365
Container-title:American Journal of Respiratory Medicine
language:en
Short-container-title:Am J Respir Med

Author:

Soriano Joan B.,Kiri Victor A.,Pride Neil B.,Vestbo Jørgen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF03256640.pdf

Reference29 articles.

1. The World Health Report 1998. Life in the 21st century: a vision for all. Geneva: World Health Organization, 1998

2. Friedman M, Hilleman DE. Economic burden of chronic obstructive pulmonary disease: impact of new treatment options. Pharmacoeconomics 2001; 19: 245–54

3. LAIA: Lung & Asthma Information Agency. Trends in emergency hospital admissions for lung disease. St George’s Hospital Medical School, London, UK. 1999 Factsheet 99/2

4. The COPD Guidelines Group of the Standards of Care Committee of the BTS. 1998 BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52Suppl. 5: S1–28

5. Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297–303

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COPD – do the right thing;BMC Family Practice;2021-12

2. Predicting and preventing hospital readmission for exacerbations of COPD;ERJ Open Research;2020-04

3. Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease;Drugs - Real World Outcomes;2019-12-02

4. Micro and macro analysis on the burden of COPD hospitalizations on the Bulgarian healthcare system;Biotechnology & Biotechnological Equipment;2019-01-01

5. Observational Studies of Inhaled Corticosteroid Effectiveness in COPD;Chest;2018-08